TLSINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as TLSIW
TriSalus Life Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.53−0.10 (-2.75%)
Close on Oct 19, 2026
- Market cap
- $205.79M
- P/E (TTM)
- –
- Dividend yield
- –
TriSalus Life Sciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Market Cap | $217.36M | $230.55M |
| Enterprise Value | $204.14M | $202.97M |
| PS Ratio | 4.82 | 3.11 |
| PB Ratio | 33.18 | 3.14 |
| P/TBV Ratio | 33.18 | 4.57 |
Enterprise value
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| EV / Sales | 4.53 | 2.92 |
Income (trailing twelve months)
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Revenue | $45.08M | $102.39M |
| Gross Profit | $38.67M | $60.36M |
| Operating Income | -$30.51M | -$4.31M |
| Pretax Income | -$28.20M | -$2.26M |
| Net Income | -$28.21M | -$6.57M |
| EBITDA | -$29.95M | -$1.98M |
| EPS (Diluted) | -$1.30 | -$0.07 |
Margins
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Gross Margin | 85.8% | 55.1% |
| Operating Margin | -67.7% | -6.04% |
| Pretax Margin | -62.6% | -4.11% |
| Profit Margin | -62.6% | -10.5% |
| EBITDA Margin | -66.4% | -2.67% |
| FCF Margin | -51.6% | -0.30% |
Returns
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Return on Assets (ROA) | -54.4% | -13.3% |
| Return on Capital Employed (ROCE) | -59.5% | -9.07% |
Growth
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 25.2% | 8.85% |
| Revenue Growth (3Y CAGR) | 53.9% | 7.08% |
Balance sheet
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $46.29M | $37.33M |
| Total Debt | $33.07M | $72.66M |
| Net Cash (Debt) | $13.22M | $3.92M |
| Net Cash Per Share | $0.21 | $0.28 |
| Equity (Book Value) | $6.55M | $57.36M |
| Book Value Per Share | $0.11 | $2.81 |
| Tangible Book Value | $6.55M | $10.71M |
| Working Capital | $48.57M | $54.64M |
Financial position
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Current Ratio | 5.35 | 2.50 |
| Quick Ratio | 4.72 | 1.54 |
| Debt / Equity | 5.05 | 0.38 |
| Interest Coverage | -5.23 | -1.81 |
Cash flow (trailing twelve months)
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$22.80M | -$653.46K |
| Capital Expenditures | -$480.00K | -$3.69M |
| Free Cash Flow | -$23.28M | -$835.02K |
| FCF Per Share | -$0.38 | -$0.02 |
Efficiency
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Asset Turnover | 0.87 | 0.59 |
| Inventory Turnover | 1.60 | 2.21 |
| Revenue Per Employee | $441.93K | $322.57K |
| Profits Per Employee | -$276.59K | -$51.88K |
| Employee Count | 102 | 185 |
Dividends and yields
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Earnings Yield | -13.0% | -6.91% |
| FCF Yield | -10.7% | -0.56% |
| Buyback Yield | -20.3% | 0.78% |
| Shareholder Yield | -20.3% | 0.80% |
Shares
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Shares Outstanding | 61,574,600 | 44,856,700 |
| Shares Change (YoY) | 73.8% | 3.35% |
| Shares Change (QoQ) | 0.09% | 0.27% |
| Float | 43,285,200 | 37,097,900 |
| Shares Held by Insiders | 29.7% | 10.6% |
| Shares Held by Institutions | 38.6% | 63.5% |
Taxes
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Income Tax | $13.00K | $1.52M |
Scores
| Measure | TriSalus Life Sciences | Industry median |
|---|---|---|
| Altman Z-Score | -5.21 | 1.95 |
| Piotroski F-Score | 3 | 5 |
| Beneish M-Score | -5.05 | -2.64 |
Calculated by StockData from TriSalus Life Sciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.